Cargando…

Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity

Type 2 diabetes (T2D) and Alzheimer’s diseases (AD) represent major health issues that have reached alarming levels in the last decades. Although growing evidence demonstrates that AD is a significant comorbidity of T2D, and there is a ~1.4–2-fold increase in the risk of developing AD among T2D pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrano, Nicola, Biondi, Giuseppina, Borrelli, Anna, Rella, Martina, Zambetta, Tommaso, Di Gioia, Ludovico, Caporusso, Mariangela, Logroscino, Giancarlo, Perrini, Sebastio, Giorgino, Francesco, Natalicchio, Annalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855893/ https://www.ncbi.nlm.nih.gov/pubmed/36671568 http://dx.doi.org/10.3390/biom13010183

Ejemplares similares

Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity
por: Marrano, Nicola, et al.
Publicado: (2021)

Effects of Extra Virgin Olive Oil Polyphenols on Beta-Cell Function and Survival
por: Marrano, Nicola, et al.
Publicado: (2021)

Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes
por: Biondi, Giuseppina, et al.
Publicado: (2022)

Implicazioni cliniche extraglicemiche dell’insulino-resistenza
por: Caporusso, Mariangela, et al.
Publicado: (2022)

Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
por: Leonardini, Anna, et al.
Publicado: (2009)

Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
por: Castellana, Marco, et al.
Publicado: (2020)

Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
por: Cignarelli, Angelo, et al.
Publicado: (2022)

Insulin and Insulin Receptors in Adipose Tissue Development
por: Cignarelli, Angelo, et al.
Publicado: (2019)

Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
por: Castellana, Marco, et al.
Publicado: (2019)

Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies
por: Caruso, Irene, et al.
Publicado: (2022)

Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis
por: Caruso, Irene, et al.
Publicado: (2023)

Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis
por: Cignarelli, Angelo, et al.
Publicado: (2020)

The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
por: D'Oria, Rossella, et al.
Publicado: (2020)

Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity
por: Palma, Giuseppe, et al.
Publicado: (2022)

Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System
por: D’Oria, Rossella, et al.
Publicado: (2022)

Effects of CPAP on Testosterone Levels in Patients With Obstructive Sleep Apnea: A Meta-Analysis Study
por: Cignarelli, Angelo, et al.
Publicado: (2019)

Role of Glucose-Lowering Medications in Erectile Dysfunction
por: Cignarelli, Angelo, et al.
Publicado: (2021)

Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine?
por: Genchi, Valentina Annamaria, et al.
Publicado: (2021)

TNFα Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells
por: Laviola, Luigi, et al.
Publicado: (2013)

Pharmacological modulation of adaptive thermogenesis: new clues for obesity management?
por: Genchi, V. A., et al.
Publicado: (2023)

Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis
por: Garruti, Gabriella, et al.
Publicado: (2023)

Differences in Gene Expression and Cytokine Release Profiles Highlight the Heterogeneity of Distinct Subsets of Adipose Tissue-Derived Stem Cells in the Subcutaneous and Visceral Adipose Tissue in Humans
por: Perrini, Sebastio, et al.
Publicado: (2013)

Autophagy: A Cellular Guardian against Hepatic Lipotoxicity
por: Sinha, Rohit Anthony
Publicado: (2023)

HILPDA is a lipotoxic marker in adipocytes that mediates the autocrine negative feedback regulation of triglyceride hydrolysis by fatty acids and alleviates cellular lipotoxic stress
por: Deng, Lei, et al.
Publicado: (2023)

Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action
por: Tirabassi, Giacomo, et al.
Publicado: (2015)

Improvement of Lipotoxicity-Induced Islet β Cellular Insulin Secretion Disorder by Osteocalcin
por: Zhang, Yafang, et al.
Publicado: (2022)

An update on the use of gamma (multi)sensory stimulation for Alzheimer’s disease treatment
por: Manippa, Valerio, et al.
Publicado: (2022)

NANOG Plays a Hierarchical Role in the Transcription Network Regulating the Pluripotency and Plasticity of Adipose Tissue-Derived Stem Cells
por: Pitrone, Maria, et al.
Publicado: (2017)

Sexual dimorphism in inorganic mercury toxicokinetics and the attendant lipotoxic and non-lipotoxic dyslipidemia in the rat
por: Wusu, A.D., et al.
Publicado: (2021)

Identification of genes that regulate multiple cellular processes/responses in the context of lipotoxicity to hepatoma cells
por: Srivastava, Shireesh, et al.
Publicado: (2007)

Glutamine Modulates Macrophage Lipotoxicity
por: He, Li, et al.
Publicado: (2016)

The Role of Lipotoxicity in Smoke Cardiomyopathy
por: Santos, Priscila P., et al.
Publicado: (2014)

Nutrition, frailty, and Alzheimer's disease
por: Panza, Francesco, et al.
Publicado: (2014)

Lipotoxicity and Decreased Islet Graft Survival
por: Leitão, Cristiane B., et al.
Publicado: (2010)

RNA Regulation of Lipotoxicity and Metabolic Stress
por: Caputa, George, et al.
Publicado: (2016)

Lipid droplets and lipotoxicity during autophagy
por: Nguyen, Truc B., et al.
Publicado: (2017)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)

Exploiting lipotoxicity for the treatment of liver cancer
por: Rudalska, Ramona, et al.
Publicado: (2021)

Prevention of Lipotoxicity in Pancreatic Islets with Gammahydroxybutyrate
por: Yung, Justin Hou Ming, et al.
Publicado: (2022)

The Contribution of Lipotoxicity to Diabetic Kidney Disease
por: Schelling, Jeffrey R.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m9e05c7ob6pjb050pqpbeohhqg